All Type of News
Korean impotence patients prefer Cialis to Viagra.
Prof. Ahn Tae-young of Seoul Asan hospital reported in the 57th annual meeting of the Korea Society of Urology at Sheraton Walker hill hotel on Nov. 18 that Korean impotence patients accepted 3 times more favors of Ci...
NHI reimbursement for 127 drugs newly approved.
The MOHW announced newly revised ordinance on Nov. 16 that the total 127 drugs were included to the NHI reimbursement scheme effective from Dec. 1, 2005 whereas the total 371 drugs including 136 of reimbursable and 21...
Incentive plan for cheaper drug uses urgently needed at hospitals.
Dr. Lee Gyeong-hee of the Korea Institute for Health and Social Affairs (KIHSA) presented in the talk meeting for the NHI drug price review at Rep. Park Jae-wan's office on Nov. 17 that an economic incentive plan for ...
Fair Trade Act also applicable to non NHI reimbursable drugs.
The current Fair Trade Act allows a free drug sample for physicians and medical institutions with one smallest package and once only, which shall be applicable not only NHI drugs but also the non NHI reimbursable drug...
Exclusive Drug Purchase Card system to adopt by year end.
Mr. Song Jae-chan of MOHW said in the drug price review meeting at Rep. Park Jae-wan office on Nov. 17 that "Exclusive drug purchase card" system should be prepared by the end of this year in an attempt to enhance a d...
Handok awarded for environment friendly business
In the workshop for the environment friendly business at the International Exhibition Center located at Koyang city, the MOE's appointed Handok to award for the company environment friendly business practices and the ...
Il Yang to develop Star Anise products for AI.
Il Yang said that the company succeeded in developing a new remedy for the treatment of Avian influenza (AI) in separation to Roche's Tamiflu by using the same major substance of Tamiflu, named Star Anise, which expec...
Listed drug companies to overcome slow sales with profitability.
According to the management analysis for the listed pharmaceutical companies of the fiscal year ended at Dec. 31, the total sales up to 3/4 of 2005 reported at 3,171,900 million won, which was 6.17% up from the previo...
Drug makers to perform favorable sales and profits in 1/2 of 2005.
In contrast to the listed pharmaceutical companies of the fiscal year ended at Dec. 31, the business performance of the listed pharmaceutical companies with a fiscal year ended at March 31 during the first half of the...
MOIE to investigate Gemcitabine patent infringement.
The Trade Commission of the Ministry of Industry and Energy took the 225th meeting on Nov. 12 and decided to investigate an unfair trade act by infringing the patent rights of gemcitabine, an anti-cancer drug owned by...
